Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes
- 1 May 2021
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 43 (9) , 2663-2671
Abstract
Background: Parotid gland mucoepidermoid carcinoma (MEC) has published five‐year cancer‐specific survival (CSS) rates of 77%–97%, with variance related to grade.Methods: Patients receiving primary surgery for parotid gland MEC from 1995 to 2014 at a tertiary medical center underwent clinical review, histopathologic review, and cytogenetic analysis. Survival outcomes were evaluated.Results: Among 58 patients, T/N/M classification was as follows: T1 in 35 patients, T2 in 14, T4a in 9, N0 in 53, N1 in 2, N2b in 3. Histologic grade was low in 27, intermediate in 17, and high in 12 patients with 98% MAML2 positivity. All patients underwent parotidectomy, and seven patients received adjuvant radiation therapy. CSS was 100% at 5 years and 94.1% at 10 and 15 years. Two patients experienced locoregional recurrence.Conclusions: Treatment with adequate surgical resection and adjuvant radiation therapy for high‐grade or advanced‐stage tumors yields excellent survival, independent of clinical stage or pathologic grade.Keywords
This publication has 26 references indexed in Scilit:
- Mucoepidermoid CarcinomaAmerican Journal of Surgical Pathology, 2019
- New Developments in Salivary Gland Pathology: Clinically Useful Ancillary Testing and New Potentially Targetable Molecular AlterationsArchives of Pathology & Laboratory Medicine, 2017
- AJCC Cancer Staging Manual2017
- Classification of parotidectomies: a proposal of the European Salivary Gland SocietyEuropean Archives of Oto-Rhino-Laryngology, 2016
- Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population‐level analysis of 2400 patientsHead & Neck, 2013
- Determinants of survival in parotid gland carcinoma: a population-based studyAmerican Journal of Otolaryngology, 2005
- Mucoepidermoid Carcinoma of the Parotid GlandJAMA Otolaryngology–Head & Neck Surgery, 2004
- t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayNature Genetics, 2003
- Mucoepidermoid CarcinomaAmerican Journal of Surgical Pathology, 2001
- Mucoepidermoid carcinoma of salivary gland originThe American Journal of Surgery, 1978